Khadija Benlhassan
Technik-/Wissenschafts-/F&E-Leiter bei IMMUNOCLIN CORP
Profil
Khadija Benlhassan is currently working as the Chief Scientific Officer at Immunoclin Corp.
She has a graduate degree from Université de Paris 5 René Descartes.
Aktive Positionen von Khadija Benlhassan
| Unternehmen | Position | Beginn |
|---|---|---|
| IMMUNOCLIN CORP | Technik-/Wissenschafts-/F&E-Leiter | 01.03.2014 |
Ausbildung von Khadija Benlhassan
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Immunoclin Corp.
 Immunoclin Corp. BiotechnologyHealth Technology Immunoclin Corp. operates as an healthcare company. Its products include Multi-Variant Atherosclerosis Risk Assessment, Genetic Alzheimer's Risk Discovery, PRIMALEUKIN, and interleukin-22. The company was founded on February 8, 2011 and is headquartered in Washington, DC. | Health Technology |
| Université de Paris 5 René Descartes | Consumer Services |
